Table 2.
Mol ID | Molecule Name | Targets Number | Targets |
---|---|---|---|
MOL004440 | Peimisine | 16 | NR3C1 |
MOL004440 | Peimisine | NOS3 | |
MOL004440 | Peimisine | DPP4 | |
MOL004440 | Peimisine | CCR3 | |
MOL004440 | Peimisine | DRD2 | |
MOL004440 | Peimisine | CCR1 | |
MOL004440 | Peimisine | VDR | |
MOL004440 | Peimisine | MDM2 | |
MOL004440 | Peimisine | SRC | |
MOL004440 | Peimisine | MMP13 | |
MOL004440 | Peimisine | MMP2 | |
MOL004440 | Peimisine | GSK3B | |
MOL004440 | Peimisine | BCL2 | |
MOL004440 | Peimisine | ADRB2 | |
MOL004440 | Peimisine | ADRB1 | |
MOL004440 | Peimisine | CA4 | |
MOL009596 | Sinpemine | 15 | CHRM2 |
MOL009596 | Sinpemine | CHRM1 | |
MOL009596 | Sinpemine | REN | |
MOL009596 | Sinpemine | MDM2 | |
MOL009596 | Sinpemine | DPP4 | |
MOL009596 | Sinpemine | ADRB2 | |
MOL009596 | Sinpemine | CCR1 | |
MOL009596 | Sinpemine | CCR3 | |
MOL009596 | Sinpemine | NR3C1 | |
MOL009596 | Sinpemine | CHRNA3 | |
MOL009596 | Sinpemine | CXCR3 | |
MOL009596 | Sinpemine | DRD2 | |
MOL009596 | Sinpemine | BCL2 | |
MOL009596 | Sinpemine | TNF | |
MOL009596 | Sinpemine | ACE | |
MOL000358 | Beta-sitosterol | 12 | PTGS1 |
MOL000358 | Beta-sitosterol | PTGS2 | |
MOL000358 | Beta-sitosterol | CHRM3 | |
MOL000358 | Beta-sitosterol | CHRM1 | |
MOL000358 | Beta-sitosterol | CHRM2 | |
MOL000358 | Beta-sitosterol | ADRB2 | |
MOL000358 | Beta-sitosterol | SLC6A4 | |
MOL000358 | Beta-sitosterol | BCL2 | |
MOL000358 | Beta-sitosterol | BAX | |
MOL000358 | Beta-sitosterol | JUN | |
MOL000358 | Beta-sitosterol | CASP3 | |
MOL000358 | Beta-sitosterol | PON1 | |
MOL001749 | ZINC03860434 | 3 | CHRM3 |
MOL001749 | ZINC03860434 | ADRB2 | |
MOL001749 | ZINC03860434 | CHRM1 | |
MOL009593 | Verticinone | 3 | BCL2 |
MOL009593 | Verticinone | BAX | |
MOL009593 | Verticinone | CASP3 | |
MOL009589 | Korseverinine | 2 | CHRM2 |
MOL009589 | Korseverinine | NR3C1 | |
MOL009027 | Cyclopamine | 1 | NR3C1 |
Abbreviations: CBM, Chuanbeimu; ID, Identity document.